ALISO VIEJO, Calif., Aug. 9, 2012 /PRNewswire/ -- Microsemi Corporation (Nasdaq: MSCC), a leading provider of semiconductor solutions differentiated by power, security, reliability and performance, today announced the appointment of James V. Mazzo to its board of directors.
Mazzo currently serves as senior vice president, Abbott Medical Optics. Abbott is a global leader in advanced refractive technologies for eye care professionals and patients. Headquartered in Santa Ana, Calif., AMO offers market-leading technologies and services designed to address vision disorders at all stages of life. He led the company through a 2002 spin-off from Allergan Inc., and its 2009 sale to Abbott.
Prior to leading AMO, Mazzo progressed throughout a 22-year career at Allergan, where he held a variety of senior executive-level positions. He spent approximately 12 years working outside the United States, serving as president of Allergan's Europe/Africa/Middle East region, vice president and managing director in Italy, and director of marketing in Canada.
Mazzo lends his expertise to a number of nonprofit organizations, associations and higher education institutions, including: Foundation of the American Academy of Ophthalmology; International Intraocular Implant Club; OCTANe board of directors; Chapman University board of trustees; University of San Diego board of trustees; and the University of California, Irvine Dean's board of directors' Executive Committee and Dean's Board of Business and Engineering. He also recently completed a term as chairman of AdvaMed and is a former member of the Beckman Coulter board of directors.
Microsemi and the Microsemi logo are registered trademarks or service marks of Microsemi Corporation and/or its affiliates. Third-party trademarks and service marks mentioned herein are the property of their respective owners.